Dupuytren's Disease News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer - FDA.gov



Medscape
 
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer 
FDA.gov
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood. Zelboraf ... liver damage (hepatotoxicity ...
First Tx for Erdheim-Chester Disease, a Rare Blood Cancer Medscape
FDA Approves Zelboraf to Treat Rare Blood Cancer Curetoday.com
FDA approves Vemurafenib for patients with Erdheim-Chester Disease Week Facts

all 55 news articles » 


Men with Peyronie's disease may have increased risk for cancer - Healio



Men's Health
 
Men with Peyronie's disease may have increased risk for cancer 
Healio
?We know that a genetic association exists between Peyronie's disease and two other fibrotic conditions ? Dupuytren's disease and Ledderhose disease,? Pastuszak said. ?We also know that there are other chronic conditions that are genetically linked ...
The Curve In Your Penis Might Be a Sign of Cancer Men's Health
Peyronie's Disease: Men With Curved Penises Have Higher Cancer Risk International Business Times
Men with a curved penis have a significantly higher risk of various cancers Information-Analytic Agency NEWS.am (press release) (blog)
Newburgh Gazette  -Telegraph.co.uk  -Yahoo Style UK 
all 41 news articles » 


World Dupuytrens Contracture Market 2017 Revenue, Shares, Analysis and Forecasts till 2023 - Digital Journal



Digital Journal
 
World Dupuytrens Contracture Market 2017 Revenue, Shares, Analysis and Forecasts till 2023 
Digital Journal
The Global Dupuytrens Contracture Market has been segmented on the basis of types, diagnosis, surgery, drugs, therapy and end users. The report explores comprehensive analysis of the market with respect to various countries in the four main ...
The Healthy Geezer: Hand disorders range from annoying to crippling Times Herald-Record

all 2 news articles » 


Dupuytrens Contracture Market by Diagnosis, Surgery, Drugs, Therapy, Analysis and Forecasts to 2023 - Digital Journal



Dupuytrens Contracture Market by Diagnosis, Surgery, Drugs, Therapy, Analysis and Forecasts to 2023 
Digital Journal
The World Dupuytrens Contracture Market is expected to reach USD 5.5 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.4 % during the forecast period 2017-2023. The Global Dupuytrens Contracture Market report provides segmentation ...

and more » 


BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results - PR Newswire (press release)



BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results 
PR Newswire (press release)
Royalty revenue increased by $0.4 million for the 2017 quarter as compared to the 2016 quarter primarily due to increased sales of XIAFLEX for the treatment of Peyronie's disease and Dupuytren's contracture, whereas total revenue was lower due to the ...

and more » 


PGA golfer Tim Herron talks about Dupuytren's Contracture - The Manila Times



The Manila Times
 
PGA golfer Tim Herron talks about Dupuytren's Contracture 
The Manila Times
Minnesota golfer Tim Herron has four PGA Tour wins and a top-10 finish at the 1999 US Open on his résumé. Recently, he also became a spokesperson to raise awareness about Dupuytren's Contracture, a condition from which he suffers that limits the ...

 


BioSpecifics Technologies Corp. to Present at the Stifel 2017 Healthcare Conference - PR Newswire (press release)



KL Daily
 
BioSpecifics Technologies Corp. to Present at the Stifel 2017 Healthcare Conference 
PR Newswire (press release)
Injectable collagenase is marketed as XIAFLEX® in the U.S. for the treatment of Dupuytren's contracture and Peyronie's disease by BioSpecifics' partner, Endo International plc (Endo). XIAFLEX® is also commercialized in Japan, Europe, Canada and ...
Biospecifics Technologies Corp - BSTC - Stock Price Today - Zacks Zacks Investment Research

all 26 news articles » 


Frontline Alecensa Approved for Lung Cancer Treatment - Curetoday.com



Curetoday.com
 
Frontline Alecensa Approved for Lung Cancer Treatment 
Curetoday.com
?In our pivotal study, Alecensa significantly extended the time that people lived without their disease worsening compared to crizotinib and also showed a marked reduction in the risk of their cancer spreading to the brain.? ... damage (hepatotoxicity ...

and more » 


Endo Reports Third-Quarter 2017 Financial Results - PR Newswire (press release)



Endo Reports Third-Quarter 2017 Financial Results 
PR Newswire (press release)
During third-quarter 2017, Endo, in partnership with Tim Herron, a four-time PGA Tour winner, and Damon Adamany, MD, of the CORE Institute, launched Facts on Hand, an unbranded campaign to raise awareness of Dupuytren's Contracture, a progressive, ...

and more » 


Why Endo International plc ? Ordinary Shares (NASDAQ:ENDP) Jumped Over 13%? - WallStreetPR



WallStreetPR
 
Why Endo International plc ? Ordinary Shares (NASDAQ:ENDP) Jumped Over 13%? 
WallStreetPR
During Q3 2017, Endo, in association with Tim Herron, introduced Facts on Hand, an unbranded drive to increase awareness of Dupuytren's Contracture, a growing, potentially disfiguring hand condition. The company also recently introduced numerous ...
7 Stocks of the Month: December Edition Zacks.com

all 103 news articles »